Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Jiheon SongVimoj Nair

Abstract

Primary central nervous system lymphoma (PCNSL) is a very rare type of malignancy with a poor prognosis. The role of whole brain radiotherapy (WBRT) in PCNSL has been questioned due to the significant neurotoxicity and lack of convincing data for survival benefit. Even its role in a palliative setting remains to be clearly elucidated. Our study aims to investigate the benefit of WBRT in patients who are ineligible for systemic therapy. A single-institution retrospective study was conducted on patients diagnosed with PCNSL between 2002 and 2017. Patients were excluded if they received systemic therapy or focal radiation only. Data on patient demographics and WBRT were collected and correlated with clinical outcomes. A total of 48 patients were selected for analysis, among which 31 (64.6%) patients received WBRT and 17 (35.4%) patients received supportive care only. Patient baseline characteristics were similar between the two groups. Median overall survival (OS) was 4.3 months among the entire cohort. WBRT was associated with improved median OS (8.0 months, range 1.4-62.3 months) compared with supportive care only (3.3 months, range 0.7-18.3 months) (HR 0.39, 95% CI 0.20-0.75, p = 0.005). Among patients who received WBRT, higher...Continue Reading

References

Oct 1, 1974·Cancer·J M HenryR L Davis
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L E AbreyJ Yahalom
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L E AbreyL M DeAngelis
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrés J M FerreriFranco Cavalli
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Yuta ShibamotoNaofumi Hayabuchi
Jul 26, 2006·International Journal of Radiation Oncology, Biology, Physics·Nadia N LaackUNKNOWN North Central Cancer Treatment Group
Feb 8, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D D CorreaD Schiff
Dec 21, 2010·Journal of Neuro-oncology·Antonio OmuroUNKNOWN ANOCEF Group (French Neuro-Oncology Association)
Sep 15, 2011·British Journal of Cancer·J L VillanoB J McCarthy
Jul 13, 2014·Neuro-oncology·Lisa M DeAngelis
Apr 22, 2017·Critical Reviews in Oncology/hematology·Giovanni CitterioAndrés José Maria Ferreri
Dec 10, 2017·Hematology·Andrés José María Ferreri

❮ Previous
Next ❯

Citations

Dec 20, 2020·Journal of Applied Clinical Medical Physics·Jesang YuEun Kyung Choi
Aug 28, 2021·British Journal of Haematology·Nicolas Martinez-CalleElisabeth Schorb

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Christopher J Schultz, Joseph Bovi
Clinical Medicine Insights. Oncology
Prathima Prodduturi, Philip J Bierman
Clinical Oncology : a Journal of the Royal College of Radiologists
W KongW J Mackillop
© 2021 Meta ULC. All rights reserved